PAP Devices Market Size, Share, Forecast, & Trends Analysis by Type [CPAP, BiPAP, APAP, Accessories (Masks, Headgear)], Disease [Obstructive Sleep Apnea, COPD, Respiratory Failure] End User [Hospitals, Home Healthcare Settings]

Description

List of Tables

PAP Devices Market Size, Share, Forecast, & Trends Analysis by Type [CPAP, BiPAP, APAP, Accessories (Masks, Headgear)] Disease [Obstructive Sleep Apnea, COPD, Respiratory Failure] End User [Hospitals, Home Healthcare Settings]-Global Forecast to 2031

The PAP devices market is projected to reach $6.97 billion by 2031 at a CAGR of 5.2% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the global PAP positive airway pressure (PAP) devices market is driven by the increasing prevalence of respiratory and sleeping disorders, the rising geriatric population suffering from respiratory disorders, the introduction of new sleep apnea devices, growing awareness about the adverse impacts of untreated sleep apnea, and favorable reimbursement policies for sleep apnea therapies and devices. However, PAP devices are expensive and not suitable for patients with certain conditions, which restrains the market's growth.

Furthermore, technological advancements in PAP devices and the rising focus on out-of-hospital healthcare are expected to offer significant market growth opportunities. However, the side effects of PAP devices and the low adherence rate for sleep apnea devices are challenging the market's growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the last three to four years. The key players operating in the PAP devices market are ResMed Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Inspire Medical Systems, Inc. (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Rotech Healthcare Inc. (U.S.), Cardinal Health, Inc. (U.S.), Invacare Corporation (U.S.), Cleveland Medical Devices Inc. (U.S.), BMC Medical Co., Ltd. (China), Lowenstein Medical Technology GmbH + Co. KG. (Germany), SomnoMed, Inc. (Australia), Drive DeVilbiss Healthcare Ltd. (U.S.), and SunMed, LLC (U.S.)

Among all the products covered in this report, in 2024, the continuous positive airway pressure (CPAP) devices segment is expected to account for the largest share of 68.2% of the PAP devices market. The availability of technologically advanced CPAP machines and compact designs of devices are supporting the largest share of the market. Patient-friendly nature of CPAP devices results in higher adoption and usage. Additionally, CPAP devices are increasingly used for sleep-related disorders. The rising prevalence of sleep disorders such as insomnia further supports the large market share of this segment.

Among all the diseases covered in this report, in 2024, the obstructive sleep apnea (OSA) segment is expected to account for the largest share of the PAP devices market. Adverse impacts of obstructive sleep apnea (OSA), such as the rise of heart-related issues or diabetes, create a need for the usage of PAP devices for obstructive sleep apnea (OSA). The market players are introducing new devices specifically for the treatment of obstructive sleep apnea (OSA), positively impacting the market.

Among all the end users covered in this report, in 2024, the hospitals and sleep clinics segment is expected to account for the largest share of 60.9% of the PAP devices market. The rising prevalence of sleep apnea, dedicated infrastructure in hospitals for sleep clinics, and a large pool of patients visiting hospitals and clinics for the treatment of sleep disorders are the factors attributed to the segment's large share.

An in-depth analysis of the geographical scenario of the PAP devices market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Among all the geographies studied in this report, in 2024, North America is expected to account for the largest share of 41.5% of the PAP devices market. The large share of this regional market is attributed to the developed healthcare infrastructure in the U.S. and Canada, higher adoption of technologically advanced medical devices in the region, high spending on healthcare, and the presence of key market players.

Scope of the Report:

PAP Devices Market Size & Trends Analysis-by Product

Continuous Positive Airway Pressure (CPAP) Devices
Bilevel Positive Airway Pressure (BiPAP) Devices
Automatic Positive Airway Pressure (APAP) Devices
Accessories
- Masks
Full Face Masks
Nasal Masks
Nasal Pillows/Cushion Masks
- Headgear
- Other Accessories

Note: Other accessories include air filters, CPAP pillow, nasal pads, and power adapters & batteries.

PAP Devices Market Size & Trends Analysis-by Disease

Obstructive Sleep Apnea (OSA)
Respiratory Failure
Chronic Obstructive Pulmonary Disease (COPD)
Heart Failure

PAP Devices Market Size & Trends Analysis-by End User

Hospitals and Sleep Clinics
Home Healthcare Settings

PAP Devices Market Size & Trends Analysis-by Geography

North America
- U.S.
- Canada
Europe
- Germany
- France
- Italy
- U.K.
- Spain
- Switzerland
- Netherlands
- Sweden
- Belgium
- Denmark
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa

Product Code: MRHC - 104851

1. Overview

1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Process of Data Collection and Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
- 2.3.3. Market Share Analysis
2.4. Assumptions for the Study

3. Executive Summary

4. Factors Affecting Market Growth

4.1. Overview
4.2. Drivers
- 4.2.1. Increasing Prevalence of Respiratory and Sleep Disorders
- 4.2.2. Increasing Geriatric Population Suffering from Respiratory Disorders
- 4.2.3. Product Launches and Approvals for PAP Devices
- 4.2.4. Growing Awareness about the Adverse Impacts of Untreated Sleep Apnea
- 4.2.5. Favorable Reimbursement Policies for Sleep Apnea Therapies and Devices
4.3. Restraints
- 4.3.1. High Costs of PAP Devices
- 4.3.2. Unsuitability for Patients with Certain Conditions
4.4. Opportunities
- 4.4.1. Technological Advancements in PAP Devices
- 4.4.2. Rising Focus on Out-Of-Hospital Healthcare
4.5. Challenges
- 4.5.1. Side Effects of PAP Devices
- 4.5.2. Less Adherence Rate for Sleep Apnea Devices
4.6. Trends
- 4.6.1. Integration of Smart Features in PAP Devices
4.7. Pricing Analysis
4.8. Regulatory Analysis
4.9. Porter's Five Forces Analysis

5. Global PAP Devices Market Assessment-by Product

5.1. Overview
5.2. Continuous Positive Airway Pressure (CPAP) Devices
5.3. Bilevel Positive Airway Pressure (BiPAP) Devices
5.4. Automatic Positive Airway Pressure (APAP) Devices
5.5. Accessories
- 5.5.1. Masks
  - 5.5.1.1. Full Face Masks
  - 5.5.1.2. Nasal Masks
  - 5.5.1.3. Nasal Pillows/Cushion Masks
- 5.5.2. Headgear
- 5.5.3. Other Accessories

6. Global PAP Devices Market Assessment-by Disease

6.1. Overview
6.2. Obstructive Sleep Apnea (OSA)
6.3. Respiratory Failure
6.4. Chronic Obstructive Pulmonary Disease (COPD)
6.5. Heart Failure

7. Global PAP Devices Market Assessment-by End User

7.1. Overview
7.2. Hospitals and Sleep Clinics
7.3. Home Healthcare Settings

8. PAP Devices Market Assessment-by Geography

8.1. Overview
8.2. North America
- 8.2.1. U. S.
- 8.2.2. Canada
8.3. Europe
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Switzerland
- 8.3.7 Netherlands
- 8.3.8. Sweden
- 8.3.9. Belgium
- 8.3.10. Denmark
- 8.3.11. Rest of Europe
8.4. Asia-Pacific
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. South Korea
- 8.4.5. Australia
- 8.4.6. Rest of Asia-Pacific
8.5. Latin America
- 8.5.1. Brazil
- 8.5.2 Mexico
- 8.5.3. Argentina
- 8.5.4. Rest of Latin America
8.6. Middle East & Africa
- 8.6.1. Saudi Arabia
- 8.6.2. UAE
- 8.6.3. South Africa
- 8.6.4. Rest of Middle East & Africa

9. Competition Analysis

9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
- 9.4.1. Industry Leaders
- 9.4.2. Market Differentiators
- 9.4.3. Vanguards
- 9.4.4. Emerging Companies
9.5. Market Share Analysis/Market Rankings (2023)

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

10.1. ResMed Inc.
10.2. Koninklijke Philips N.V.
10.3. Inspire Medical Systems, Inc.
10.4. Fisher & Paykel Healthcare Corporation Limited
10.5. Medtronic plc
10.6. Rotech Healthcare Inc.
10.7. Cardinal Health, Inc.
10.8. Invacare Corporation
10.9. Cleveland Medical Devices Inc.
10.10. BMC Medical Co., Ltd.
10.11. Lowenstein Medical Technology GmbH + Co. KG.
10.12 SomnoMed, Inc.
10.13 Drive DeVilbiss Healthcare Ltd.
10.14 SunMed, LLC
10.15 Other Companies

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

11. Appendix

11.1. Available Customization
11.2. Related Reports